TickerFactsScreenerDevelopers

Entrada Therapeutics, Inc. (TRDA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$25.57M2021: -$50.86M2022: -$93.79M2023: $139.80M2024: -$41.56M2025: -$128.51M-$128.51M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$128.51M-209.2%
2024-$41.56M-129.7%
2023$139.80M+249.1%
2022-$93.79M-84.4%
2021-$50.86M-98.9%
2020-$25.57M—